Author: Ricki Lewis, PhD

Figures

Figure 1.1. Stem Cell Dividing
Figure 4.1. Tumor Neurosphere

Tables

Table 1.1. Selected Clinical Trials for Stem Cell Treatments
Table 1.2. A Comparison of Basic Stem Cell Types
Table 1.3. Reprogramming Strategies
Table 1.4. Transgenes Used to Derive Human iPS Cells
Table 1.5. Pluripotency Genes Expressed in Both ES and iPS Cells
Table 1.6. A Snapshot of Stem Cell Companies
Table 2.1.The Medical Trash Heap: Sources of Adult Stem Cells
Table 2.2. Some Characteristics of hES Cells
Table 2.3. Some hES Cell Markers
Table 2.4. Some Compounds Required To Maintain ES Cells
Table 2.5. Steps in Obtaining and Processing Stem Cells
Table 2.6. Hydrogels Used in Tissue Engineering
Table 2.7. Steps in Using Hydrogels
Table 2.8. Surface Markers of Human Stem Cell Types
Table 3.1. First Cell Lines at Harvard Stem Cell Institute’s iPS Core
Table 3.2. Selected Case and Pilot Studies with Promising Results
Table 3.3. A Wish-List for Stem Cell Therapies
Table 3.4. Some Cancer Stem Cell Markers
Table 4.1. Numbers of Potential Patients for Stem Cell Therapies
Table 4.2. Some Organizations That Fund Human Stem Cell Research
Table 4.3. Patents for ES Cells
Table 4.4. The UK Stem Cell Bank Regulatory Framework
Table 4.5. Members of the International Stem Cell Forum
Table 4.6. A Brief History of US Human ES Cell Policy
Table 4.7. A Brief History of Spanish Human ES Cell Policy